Acne Priority Partnership - Join in Today

ARTICLE DATE: May 18, 2013

HELP US IDENTIFY BETTER WAYS OF TREATING ACNE

The Acne Priority Setting Partnership was set up in November 2012 to bring together people with acne and healthcare providers in order to identify and then prioritise unanswered questions about acne treatments. We would like to invite you to take part in our survey and tell us what questions about acne treatments you’d like to see answered by new research. This is your chance to tell us what’s wrong with existing treatments and what changes you’d like to see.   

You can find the survey and more details about it by going to www.acnepsp.org. Alternatively you can text ‘spots’ to 88020 and be sent a link so you can fill in the survey from your phone. It only takes a few minutes.   

At the end of the exercise, we’ll make sure the most important questions are brought to the attention of acne researchers and those who fund their work. After sorting and refining, all the submitted questions will be entered (unattributed) into an open access database called UK DUETs (www.library.nhs.uk/duets/).  

Thank you very much for helping us with this important initiative and please encourage friends, family and colleagues to take part. We’d love to see a huge response as it will help clinicians and scientists involved in acne research make stronger cases for funding.  

Dr Alison Layton,

Consultant dermatologist,

Harrogate and District NHS Foundation Trust
 

The Acne Priority Setting Partnership is an independent group of patients and health professionals funded by the UK Dermatology Clinical Trials Network and the Society for Academic Primary Care.  It is overseen and monitored by the James Lind Alliance (www.jla.nihr.ac.uk), a not-for-profit organisation managed by the National Institute for Health Research Evaluation, Trials and Studies Co-ordinating Centre.

Acne Priority Partnership - Join in Today

Latest News

The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes

Almirall
Galderma
Glenmark
Johnson & Johnson
La Roche-Posay
LEO Pharma
Pierre Fabre
Schuco